Last reviewed · How we verify
NCT03354065
Inmediate Feeding Tolerance in Acute Pancreatitis
NA trial testing TIME OF FEEDING in Acute Pancreatitis Due to Gallstones in 59 participants. Completed in 31 August 2017.
1 July 2017
Quick facts
| Lead sponsor | Hospital Central "Dr. Ignacio Morones Prieto" |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 59 |
| Start date | 1 January 2017 |
| Primary completion | 1 July 2017 |
| Estimated completion | 31 August 2017 |
Drugs / interventions tested
- TIME OF FEEDING
Conditions studied
- Acute Pancreatitis Due to Gallstones — all drugs for Acute Pancreatitis Due to Gallstones →
Sponsor
Hospital Central "Dr. Ignacio Morones Prieto"
Who can join
Adults 15 to 85, any sex, with Acute Pancreatitis Due to Gallstones. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Objective: Determine tolerance of immediate oral intake (8 hours posterior to the beginning of treatment) against traditional management (early feeding at 48hr) in patients with mild acute pancreatitis of biliary origin. Double blind, randomized clinical trial
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03354065
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Pancreatitis Due to Gallstones
Currently open trials in the same condition.
- NCT04924868 — Ursodeoxycolic Acid for the Prevention of Relapsing Complications After Gallstone Acute Pancreatitis · Phase 3 · recruiting
Other Hospital Central "Dr. Ignacio Morones Prieto" trials
Trials by the same sponsor.
- NCT06915519 — Predictive Value Of Muscle Tone And Perfusion Index In Supraclavicular Block Success. · completed
- NCT05335655 — IV Dexmedetomidine in the Duration of Spinal Anesthesia With Hyperbaric Bupivacaine: Double Blind Randomized Trial. · Phase 3 · unknown
- NCT06289335 — Dexmedetomidine Compared to Ondansetron for Postanaesthetic Shivering in Patients Undergoing a Cesarean Section · Phase 2 · completed
- NCT04310280 — Effects of Local Insulin on Varicose Ulcers for Wound Healing · Phase 3 · completed
- NCT03876340 — Impact of a Clinical Decision Algorithm on Length of Hospital Stay and Costs of Care of Burned Patients · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03354065 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Central "Dr. Ignacio Morones Prieto"
- Last refreshed: 27 November 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03354065.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing